Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

An In Vivo PiggyBac Insertional Mutagenesis Screen Reveals Oncogenic Lesions Cooperating with Myd88 L265P

Blood (2023) 142 (Supplement 1): 525.

https://doi.org/10.1182/blood-2023-179915

Published: 2023

Journal Articles

New Suitable Eµ-Tcl1 Mouse Model for Research on BH3-Mimetics Therapy Response In Vivo

Ismini Halmer, Laura Beckmann, Gero Knittel, Hamid Kashkar, Hans Christian Reinhardt, Michael Hallek, Alexandra Da Palma Guerreiro, Lukas Peter Frenzel

Blood (2023) 142 (Supplement 1): 1454.

https://doi.org/10.1182/blood-2023-186330

Published: 2023

Journal Articles

Novel Autochthonous Mouse Models of Serve As Preclinical Tools to Investigate Pathogenesis and Treatment of MCD/C5 DLBCL

Ruth Flümann, Julia Hansen, Benedikt Pelzer, Ilmars Kisis, Tim Lohmann, Thorsten Persigehl, Nima Abedpour, Martin Peifer, Reinhard Buettner, Bastian von Tresckow, Ron Jachimowicz, Hans Christian Reinhardt, Gero Knittel

Blood (2022) 140 (Supplement 1): 3493–3494.

https://doi.org/10.1182/blood-2022-169607

Published: 2022

Journal Articles

Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma

Grace M. Pindzola, Raud Razzaghi, Rachel N. Tavory, Hang T. Nguyen, Vivian M. Morris, Moyi Li, Shreya Agarwal, Bonnie Huang, Takaharu Okada, Hans C. Reinhardt, Gero Knittel, Hamid Kashkar, Ryan M. Young, Stefania Pittaluga, Jagan R. Muppidi

Blood (2022) 140 (10): 1119–1131.

https://doi.org/10.1182/blood.2022015926

Published: 2022

Includes: Supplemental data

Journal Articles

Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53 -deficient B-cell malignancies

Blood (2022) 139 (25): 3617–3629.

https://doi.org/10.1182/blood.2021014007

Published: 2022

Includes: Supplemental data

Journal Articles

SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma

Blood (2022) 139 (4): 538–553.

https://doi.org/10.1182/blood.2021012081

Published: 2022

Includes: Supplemental data

Journal Articles

A Novel Autochthonous Mouse Model Serves As a Preclinical Evaluation Platform and Explores Dual BTK and BCL2 Inhibition for Activated B Cell-like Diffuse Large B Cell Lymphoma

Blood (2021) 138 (Supplement 1): 712.

https://doi.org/10.1182/blood-2021-146871

Published: 2021

Journal Articles

Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas

Blood (2021) 137 (20): 2785–2799.

https://doi.org/10.1182/blood.2020005244

Published: 2021

Includes: Supplemental data

Journal Articles

Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1

Blood (2021) 137 (5): 646–660.

https://doi.org/10.1182/blood.2020005734

Published: 2021

Includes: Supplemental data

Journal Articles

DNA Damage-Response Pathway in Lymphoma Determines Interactions with Macrophages By Altered PD-L1 Expression and Exosome Formation

Daniela Vorholt, PhD, Elena Izquierdo-Alvarez, PhD, Benedict Sackey, Jan Schmitz, Nadine Nickel, PhD, Stuart Blakemore, PhD, Gero Knittel, MSc, Christian Reinhardt, MD, Clemens-Martin Wendtner, Heiko Bruns, PhD, Michael Hallek, Christian Pallasch, MD

Blood (2018) 132 (Supplement 1): 275.

https://doi.org/10.1182/blood-2018-99-120264

Published: 2018

Journal Articles

FcmR Shapes BCR Signaling in IgM-Positive Leukemia

Alexandra da Palma Guerreiro, PhD, Cornelia Dorweiler, Ismini Halmer, Olaf Merkel, Elena Maria Hartmann, MD, Valeska Berg, PhD, Nina Reinart, Günter Fingerle-Rowson, MD PhD, Gero Knittel, MSc, Christian Pallasch, MD, Andreas Rosenwald, Christian Reinhardt, MD, Clemens-Martin Wendtner, Michael Hallek, MD, Lukas P. Frenzel, MD

Blood (2018) 132 (Supplement 1): 2620.

https://doi.org/10.1182/blood-2018-99-118352

Published: 2018

Journal Articles

Loss of TOSO Promotes Richter's Transformation of TCL1A Driven CLL

Alexandra da Palma Guerreiro, PhD, Cornelia Dorweiler, Laurent Kintzelé, Dunja Baatout, M.Sc., Malte Huelsemann, Valeska Berg, PhD, Olaf Merkel, Nina Reinart, PhD, Guenter Fingerle-Rowson, MD PhD, Gero Knittel, Christian Pallasch, MD, Hans Christian Reinhardt, Clemens Martin Wendtner, MD, Michael Hallek, Lukas P. Frenzel, MD

Blood (2016) 128 (22): 354.

https://doi.org/10.1182/blood.V128.22.354.354

Published: 2016

Journal Articles

Transformation of Chronic Lymphocytic Leukemia Towards Richter´s Syndrome Is Induced By AKT Activation

Nadine Nickel, PhD, Mona Al-Maarri, Martin Pal, Andreas Roth, Gero Knittel, Carmen D. Herling, MD PhD, Nina Reinart, PhD, Stephan Schäfer, MD, Elena M Hartmann, Andreas Rosenwald, MD, Wolfram Klapper, MD, Reinhard Büttner, Marco Herling, MD PhD, Jens Bruening, Christian Reinhardt, Michael Hallek, Thomas Wunderlich, PhD, Christian Pallasch, MD

Blood (2016) 128 (22): 2031.

https://doi.org/10.1182/blood.V128.22.2031.2031

Published: 2016

Journal Articles

B-cell–specific conditional expression of Myd88 p.L252P leads to the development of diffuse large B-cell lymphoma in mice

Blood (2016) 127 (22): 2732–2741.

https://doi.org/10.1182/blood-2015-11-684183

Published: 2016

Includes: Supplemental data

NARROW

An In Vivo PiggyBac Insertional Mutagenesis Screen Reveals Oncogenic Lesions Cooperating with Myd88 L265P

New Suitable Eµ-Tcl1 Mouse Model for Research on BH3-Mimetics Therapy Response In Vivo

Novel Autochthonous Mouse Models of Serve As Preclinical Tools to Investigate Pathogenesis and Treatment of MCD/C5 DLBCL

Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma

Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53 -deficient B-cell malignancies

SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma

A Novel Autochthonous Mouse Model Serves As a Preclinical Evaluation Platform and Explores Dual BTK and BCL2 Inhibition for Activated B Cell-like Diffuse Large B Cell Lymphoma

Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas

Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1

DNA Damage-Response Pathway in Lymphoma Determines Interactions with Macrophages By Altered PD-L1 Expression and Exosome Formation

FcmR Shapes BCR Signaling in IgM-Positive Leukemia

Loss of TOSO Promotes Richter's Transformation of TCL1A Driven CLL

Transformation of Chronic Lymphocytic Leukemia Towards Richter´s Syndrome Is Induced By AKT Activation

B-cell–specific conditional expression of Myd88 p.L252P leads to the development of diffuse large B-cell lymphoma in mice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only